Molecular Classification and Management of Rare Pediatric Embryonal Brain Tumors

[1] Louis DN(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820

[2] Perry A(1996)Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity J Neurosurg 85 56-65

[3] Reifenberger G(1999)Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 74-79

[4] von Deimling A(2002)Prediction of central nervous system embryonal tumour outcome based on gene expression Nature 415 436-442

[5] Figarella-Branger D(2009)Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors Cancer Cell 16 533-546

[6] Cavenee WK(2012)Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis Lancet Oncol 13 838-848

[7] Ohgaki H(2016)New brain tumor entities emerge from molecular classification of CNS-PNETs Cell 164 1060-1072

[8] Wiestler OD(2000)Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes Pediatr Dev Pathol 3 346-352

[9] Kleihues P(2009)Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes Acta Neuropathol 117 457-464

[10] Ellison DW(2014)CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity Acta Neuropathol 128 291-303

[1] Louis DN(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820

[2] Perry A(1996)Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity J Neurosurg 85 56-65

[3] Reifenberger G(1999)Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors Cancer Res 59 74-79

[4] von Deimling A(2002)Prediction of central nervous system embryonal tumour outcome based on gene expression Nature 415 436-442

[5] Figarella-Branger D(2009)Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors Cancer Cell 16 533-546

[6] Cavenee WK(2012)Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis Lancet Oncol 13 838-848

[7] Ohgaki H(2016)New brain tumor entities emerge from molecular classification of CNS-PNETs Cell 164 1060-1072

[8] Wiestler OD(2000)Pediatric neuroblastic brain tumors containing abundant neuropil and true rosettes Pediatr Dev Pathol 3 346-352

[9] Kleihues P(2009)Novel genomic amplification targeting the microRNA cluster at 19q13.42 in a pediatric embryonal tumor with abundant neuropil and true rosettes Acta Neuropathol 117 457-464

[10] Ellison DW(2014)CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity Acta Neuropathol 128 291-303